Sign up to save your podcasts
Or
Share Teva CEO on Staying Competitive in Generic Drug Market
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Teva CEO on Staying Competitive in Generic Drug Market
Kåre Schultz, CEO at Teva Pharmaceutical, talks about the company's restructuring plans as well as his outlook for drug development. He says more than 90% of U.S. pharmaceuticals are generics and one out of ten drugs is produced by Teva.
Host: Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
View all episodes
By Bloomberg
3.7
376376 ratings
Kåre Schultz, CEO at Teva Pharmaceutical, talks about the company's restructuring plans as well as his outlook for drug development. He says more than 90% of U.S. pharmaceuticals are generics and one out of ten drugs is produced by Teva.
Host: Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
More shows like Bloomberg Businessweek
View all
WSJ Your Money Briefing
1,732 Listeners
Exchanges
975 Listeners
Bloomberg Intelligence
411 Listeners
Bloomberg Surveillance
1,175 Listeners
Masters in Business
2,180 Listeners
Foundering
970 Listeners
WSJ Minute Briefing
680 Listeners
Trillions
194 Listeners
Wall Street Breakfast
1,045 Listeners
Thoughts on the Market
1,316 Listeners
Here's Why
67 Listeners
Out of Office
30 Listeners
Wall Street Week
65 Listeners
Listen to the Story
4 Listeners
Into the Metaverse
58 Listeners
Bedrock, USA
233 Listeners
Zero: The Climate Race
230 Listeners
Bloomberg Tech
62 Listeners
Bloomberg Daybreak: US Edition
87 Listeners
The Markets
84 Listeners
Bloomberg News Now
78 Listeners
The Deal with Alex Rodriguez and Jason Kelly
84 Listeners
Money Stuff: The Podcast
399 Listeners
Bloomberg Daybreak: Asia Edition
9 Listeners
Bloomberg Talks
19 Listeners
In the City
12 Listeners
Bloomberg Opinion
8 Listeners
The Cable
2 Listeners
The Sixth Bureau
120 Listeners
Stock Movers
22 Listeners